Your Health, We Care
With the approval of Elacestrant, it will become one of the important drugs in the field of advanced breast cancer treatment. At present, Elacestrant has started sales in the United States and other places, and has received widespread attention from doctors and patients.
Considering the high incidence rate of advanced breast cancer and the clinical advantages of Elacestrant, it is expected that Elacestrant will have broad market prospects in the future.
